103 related articles for article (PubMed ID: 29624324)
1. [Abnormal RNA editing and treatment strategy in neurological diseases; towards cure for ALS].
Yamashita T; Kwak S
Seikagaku; 2016 Oct; 88(5):600-8. PubMed ID: 29624324
[No Abstract] [Full Text] [Related]
2. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
3. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
Kwak S; Kawahara Y
J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
[TBL] [Abstract][Full Text] [Related]
4. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
Kwak S
Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptors: RNA editing and death of motor neurons.
Kawahara Y; Ito K; Sun H; Aizawa H; Kanazawa I; Kwak S
Nature; 2004 Feb; 427(6977):801. PubMed ID: 14985749
[TBL] [Abstract][Full Text] [Related]
6. Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA.
Kawahara Y; Sun H; Ito K; Hideyama T; Aoki M; Sobue G; Tsuji S; Kwak S
Neurosci Res; 2006 Jan; 54(1):11-4. PubMed ID: 16225946
[TBL] [Abstract][Full Text] [Related]
7. [ALS and excitatory amino acid].
Aizawa H; Kwak S
Brain Nerve; 2007 Oct; 59(10):1117-27. PubMed ID: 17969352
[TBL] [Abstract][Full Text] [Related]
8. [AMPA receptor-mediated neuronal death and amyotrophic lateral sclerosis].
Hideyama T; Kawahara Y; Kwak S
No To Shinkei; 2005 Jul; 57(7):585-98. PubMed ID: 16095220
[No Abstract] [Full Text] [Related]
9. Sporadic ALS: blame it on the editor.
Lipton SA
Nat Med; 2004 Apr; 10(4):347. PubMed ID: 15057227
[No Abstract] [Full Text] [Related]
10. New therapeutic targets for amyotrophic lateral sclerosis.
Kuzma-Kozakiewicz M; Kwiecinski H
Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
[TBL] [Abstract][Full Text] [Related]
11. Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?
Kawahara Y; Kwak S
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):131-44. PubMed ID: 16183555
[TBL] [Abstract][Full Text] [Related]
12. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.
Paez-Colasante X; Figueroa-Romero C; Sakowski SA; Goutman SA; Feldman EL
Nat Rev Neurol; 2015 May; 11(5):266-79. PubMed ID: 25896087
[TBL] [Abstract][Full Text] [Related]
13. Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?
van den Heuvel DM; Harschnitz O; van den Berg LH; Pasterkamp RJ
Trends Mol Med; 2014 Jan; 20(1):25-35. PubMed ID: 24140266
[TBL] [Abstract][Full Text] [Related]
14. Increased RNA editing in EAAT2 pre-mRNA from amyotrophic lateral sclerosis patients: involvement of a cryptic polyadenylation site.
Flomen R; Makoff A
Neurosci Lett; 2011 Jun; 497(2):139-43. PubMed ID: 21569822
[TBL] [Abstract][Full Text] [Related]
15. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.
Cleveland DW; Rothstein JD
Nat Rev Neurosci; 2001 Nov; 2(11):806-19. PubMed ID: 11715057
[No Abstract] [Full Text] [Related]
16. AMPA receptor-mediated neuronal death in sporadic ALS.
Kwak S; Hideyama T; Yamashita T; Aizawa H
Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
[TBL] [Abstract][Full Text] [Related]
17. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
Iłzecka J
Curr Opin Investig Drugs; 2006 Jan; 7(1):54-9. PubMed ID: 16425672
[TBL] [Abstract][Full Text] [Related]
18. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
[TBL] [Abstract][Full Text] [Related]
19. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Weishaupt JH; Hyman T; Dikic I
Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
[TBL] [Abstract][Full Text] [Related]
20. Edited GluR2, a gatekeeper for motor neurone survival?
Buckingham SD; Kwak S; Jones AK; Blackshaw SE; Sattelle DB
Bioessays; 2008 Nov; 30(11-12):1185-92. PubMed ID: 18937367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
